279
Participants
Start Date
October 17, 2025
Primary Completion Date
March 20, 2026
Study Completion Date
March 31, 2026
YHP2401
Total 7 days of treatment and The daily dose is tid.(YHP2401 + Placebo of YHR2402 + Placebo of YHR2403)
YHR2402
Total 7 days of treatment and The daily dose is tid.(Placebo of YHP2401 + YHR2402 + Placebo of YHR2403)
YHR2403
Total 7 days of treatment and The daily dose is tid.(Placebo of YHP2401 + Placebo of YHR2402 + YHR2403)
NOT_YET_RECRUITING
The Catholic University of Korea, Uijeongbu St. Mary's Hospital, Uijeongbu-si
NOT_YET_RECRUITING
Soonchunhyang University Hospital Bucheon, Bucheon-si
NOT_YET_RECRUITING
Hallym University Chuncheon Sacred Heart Hospital, Chuncheon
NOT_YET_RECRUITING
Ulsan University Hospital, Ulsan
NOT_YET_RECRUITING
Wonkwang University Hospital, Iksan
RECRUITING
Kangbuk Samsung Hospital, Seoul
NOT_YET_RECRUITING
The Catholic University of Korea, Eunpyeong St.Mary's Hospital, Seoul
NOT_YET_RECRUITING
Konkuk University Medical Center, Seoul
NOT_YET_RECRUITING
Kangdong Sacred Heart Hospital, Seoul
NOT_YET_RECRUITING
SMG-SNU Boramae Medical Center, Seoul
NOT_YET_RECRUITING
Korea University Guro Hospital, Seoul
Yuhan Corporation
INDUSTRY